Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

ClinicalTrials.gov ID: NCT04951076

Public ClinicalTrials.gov record NCT04951076. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double Blind, Two Arm Study to Investigate the Effects of BNC210 Tablet Formulation Compared to Placebo in Adults With Post-Traumatic Stress Disorder (PTSD)

Study identification

NCT ID
NCT04951076
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bionomics Limited
Industry
Enrollment
212 participants

Conditions and interventions

Interventions

  • BNC210 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 26, 2021
Primary completion
Jul 24, 2023
Completion
Aug 13, 2023
Last update posted
Feb 5, 2025

2021 – 2023

United States locations

U.S. sites
25
U.S. states
13
U.S. cities
25
Facility City State ZIP Site status
ATTUNE Study Clinical Trial Site Bellflower California 90706
ATTUNE Study Clinical Trial Site Beverly Hills California 90210
ATTUNE Study Clinical Trial Site Colton California 92324
ATTUNE Study Clinical Trial Site Oceanside California 92056
ATTUNE Study Clinical Trial Site Orange California 92868
ATTUNE Study Clinical Trial Site Temecula California 92591
ATTTUNE Study Clinical Trial Site Jacksonville Florida 32256
ATTUNE Study Clinical Trial Site Lauderhill Florida 33319
ATTUNE Study Clinical Trial Site Miami Lakes Florida 33016
ATTUNE Study Clinical Trial Site Orlando Florida 32801
ATTUNE Study Clinical Trial Site Overland Park Kansas 66221
ATTUNE Study Clinical Trial Site Prairie Village Kansas 66208
ATTUNE Study Clinical Trial Site New Bedford Massachusetts 02740
ATTUNE Study Clinical Trial Site Las Vegas Nevada 89102
ATTUNE Study Clinical Trial Site Berlin New Jersey 08009
ATTUNE Study Clinical Trial Site Cherry Hill New Jersey 08002
ATTUNE Study Clinical Trial Site Cedarhurst New York 11516
ATTUNE Study Clinical Trial Site Staten Island New York 10312
ATTUNE Study Clinical Trial Site North Canton Ohio 44720
ATTUNE Study Clinical Trial Site Oklahoma City Oklahoma 73106
ATTUNE Study Clinical Trial Site West Chester Pennsylvania 19380
ATTUNE Study Clinical Trial Site Memphis Tennessee 38119
ATTUNE Study Clinical Trial Site Austin Texas 78737
ATTUNE Study Clinical Trial Site Dallas Texas 75231
ATTUNE Study Clinical Trial Site Draper Utah 84020

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04951076, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04951076 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →